Drug Safety Matters artwork

Drug Safety Matters

47 episodes - English - Latest episode: 29 days ago -

Drug Safety Matters brings you the best stories from the world of pharmacovigilance. Through in-depth interviews with our guests, we cover new research and trends, and explore the most pressing issues in medicines safety today. Produced by Uppsala Monitoring Centre, the WHO Collaborating Centre for International Drug Monitoring.

Medicine Health & Fitness Science Life Sciences drug safety healthcare medicine medicines safety patient safety pharmacovigilance side effects
Homepage Google Podcasts Overcast Castro Pocket Casts RSS feed

Episodes

#28 Catching black swans – François Montastruc

February 29, 2024 08:00 - 27 minutes - 18.8 MB

Serious and unexpected adverse drug reactions – the ‘black swans’ of pharmacovigilance – can place enormous strain on safety monitoring systems. Drawing examples from the COVID-19 pandemic, François Montastruc from Toulouse University Hospital explains how we can get better at dealing with the unpredictable. Tune in to find out: What Nassim Nicholas Taleb’s ‘black swan’ theory has to do with pharmacovigilance What makes an adverse drug reaction a black, white, or grey swan  Why flexibili...

#27 When drugs damage the liver – Rita Baião

February 01, 2024 09:00 - 28 minutes - 19.6 MB

The liver is the primary site for drug metabolism in the body, but it can be severely damaged by medicines or their toxic compounds. Rita Baião from the North Lisbon University Hospital Center reviews what pharmacovigilance professionals should know about drug-induced liver injury (DILI). Tune in to find out: Who is most at risk of developing DILI How to diagnose the condition and control the damage How to assess case reports of DILI Want to know more? This infographic in Nature Review...

#26 What's trending in pharmacovigilance? – Angela Caro

December 20, 2023 08:00 - 28 minutes - 20.2 MB

What did the drug safety community achieve in 2023 and how will the field develop in 2024? As the year comes to a close, we asked Angela Caro, president of the International Society of Pharmacovigilance (ISoP), to walk us through current and future trends in pharmacovigilance. Tune in to find out: Why patient engagement is a growing priority What challenges exist in the Latin American region Which topics will be in the spotlight next year Want to know more? ISoP is a non-profit society...

#25 A week in the name of medicines safety – part 2

November 13, 2023 10:00 - 33 minutes - 24.2 MB

To mark #MedSafetyWeek, which took place from 6–12 November, we’re releasing a special two-part episode on pharmacovigilance communication campaigns. In this second part, we hear from three #MedSafetyWeek veterans – Anne-Cécile Vuillemin from the Ministry of Health in Luxembourg, Ban Al-Shimran from the Iraqi Ministry of Health, and Frieda Shigwedha from the Therapeutic Information and Pharmacovigilance Centre in Namibia – about what makes a successful campaign. Tune in to find out: Why yo...

#24 A week in the name of medicines safety – part 1

November 02, 2023 13:00 - 27 minutes - 19.9 MB

To mark #MedSafetyWeek, which takes place from 6–12 November, we’re releasing a special two-part episode on pharmacovigilance communication campaigns. In this first part, we speak to Mitul Jadeja from the Medicines and Healthcare products Regulatory Agency in the UK about under-reporting and how initiatives like #MedSafetyWeek can help draw attention to medicines safety. Tune in to find out: Why under-reporting plagues all pharmacovigilance systems What regulators can do to encourage peop...

Uppsala Reports Long Reads – The colour of signals

September 29, 2023 14:00 - 33 minutes - 24.4 MB

Herbal remedies have been used for thousands of years to treat what ails us. Yet why do we still know so little about their potential side effects compared to modern medicines? This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance news site, brought to you in audio format. Find the original article here. After the read, we speak to author Daniele Sartori to learn more about the challenges in herbal pharmacovigilance. Tune in ...

Uppsala Reports Long Reads – Empowering patients as partners

September 05, 2023 12:00 - 42 minutes - 30.7 MB

A patient's perspective can ensure safe medical care and lead to new insights that traditional research may overlook. But how do we best harness that perspective to improve patient outcomes? This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance news site, brought to you in audio format. Find the original article here. After the read, we speak to Manal Younus, who authored the article, to learn more about patient engagement and...

#23 Assessing safety in clinical trials – Marianne Lunzer & Sanja Prpić

June 27, 2023 14:00 - 31 minutes - 22.4 MB

Medicines safety monitoring is a continuous process that begins with pre-marketing clinical trials and continues with post-marketing studies to fill any gaps in knowledge. With Marianne Lunzer from AGES and Sanja Prpić from HALMED, we review the pros and cons of various study types and the importance of testing medicines on diverse populations. Tune in to find out: How pre- and post-approval safety studies are connected Why safety assessors can request studies in underrepresented populati...

#22 Reforming pharmacovigilance education – Michael Reumerman

May 08, 2023 12:00 - 32 minutes - 23.9 MB

Healthcare professionals are key players in medicines safety but they often lack the time or knowledge to report adverse drug reactions. To change that, we need to urgently rethink how we teach pharmacovigilance, argues Michael Reumerman from Amsterdam University Medical Centers. Tune in to find out: How real-life education can benefit healthcare students Which educational intervention can be most impactful How adverse drug event managers can improve pharmacovigilance Want to know more?...

#21 Unlocking the power of real-world data – Patrick Ryan

March 30, 2023 09:00 - 33 minutes - 24.3 MB

The vast amount of real-world data collected during routine clinical care is a treasure trove of safety information – but there are challenges to overcome before this rich source of evidence can be applied to pharmacovigilance. Patrick Ryan from Johnson & Johnson discusses how to harness real-world data for patient safety. Tune in to find out: How real-world data is collected and analysed Which pharmacovigilance processes will benefit most from it How to make data accessible without infr...

#20 The evidence for signals – Daniele Sartori

February 23, 2023 08:00 - 45 minutes - 33 MB

Spontaneous reports of adverse drug reactions are a common source of evidence in pharmacovigilance, but as the science evolves, so do the types of data used to find and assess signals. Uppsala Monitoring Centre’s Daniele Sartori reviews how signal detection practices have changed over time. Tune in to find out:  Which features of case reports are most often used to assess causality  Why pharmacovigilance experts should report clinical assessments clearly  How to shorten the time between ...

Uppsala Reports Long Reads – Unmasking data in the COVID-19 vaccine era

January 26, 2023 12:00 - 21 minutes - 15.4 MB

Most pharmacovigilance professionals will have heard of masking – a statistical issue where reports for one drug hide signals for other drugs. But the problem gained fresh attention when record amounts of reports began piling up for the COVID-19 vaccines. How should we be unmasking data in the COVID-19 vaccine era? This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance magazine, brought to you in audio format. Find the original ...

#19 Lessons in pandemic pharmacovigilance – Elena Rocca

December 15, 2022 08:00 - 33 minutes - 24 MB

The COVID-19 pandemic forced pharmacovigilance experts to revisit their processes to deal with unprecedented volumes of data and catch unexpected safety issues. Elena Rocca from Oslo Metropolitan University reviews the challenges of a global healthcare emergency – and what it can teach us about the science of drug safety. Tune in to find out: How to handle uncertain evidence Why clinical expertise matters in the age of big data Why pharmacovigilance requires interdisciplinary thinking  ...

#18 The IDMP standards explained – Malin Fladvad & Olle Lagerlund

September 29, 2022 08:00 - 23 minutes - 16.9 MB

The Identification of Medicinal Products (IDMP) standards promise to harmonise how pharmaceutical products and substances are described around the world. But how will that benefit patients and who will make sure the standards are properly implemented? Uppsala Monitoring Centre’s Malin Fladvad and Olle Lagerlund discuss the advantages and challenges of this global standardisation effort. Tune in to find out: What the IDMP standards cover How Uppsala Monitoring Centre will help create and m...

#17 Why we need vaccine surveillance systems – Madhava Balakrishnan

August 24, 2022 12:00 - 27 minutes - 19.9 MB

Public trust in vaccines hinges on their safety – but to make sure vaccines are safe, we must have systems in place to detect and manage any side effects. Dr Madhava Ram Balakrishnan, medical officer for vaccine safety at the World Health Organization, discusses how to build an effective vaccine surveillance system and how to respond to safety crises when they occur. Tune in to find out: How safety surveillance differs between vaccines and drugs What the most common side effects of vaccin...

#16 How drug safety can help fight resistant bugs – Jean Marie Vianney Habarugira & Albert Figueras

June 30, 2022 07:00 - 33 minutes - 24.3 MB

Managing antimicrobial resistance (AMR) will require innovative solutions from many different disciplines. Could pharmacovigilance be one of them? Jean Marie Vianney Habarugira and Albert Figueras, who have been investigating how drug safety tools could help track AMR, think it’s time the two communities joined forces for good. Tune in to find out: How to code adverse drug reactions for optimal AMR surveillance How to use pharmacovigilance networks to track resistant pathogens and falsifi...

#15 Safety of HIV medications – Henry Zakumumpa

April 29, 2022 13:00 - 33 minutes - 24 MB

With the right care, people infected with HIV can lead long and healthy lives. But as with any life-long medical treatment, it is important to acknowledge and manage any side effects. Henry Zakumumpa from Makerere University School of Public Health tells us about the potential harms of new HIV therapies and the challenges faced by pharmacovigilance specialists in Uganda. Tune in to find out: How dolutegravir-based HIV therapies compare to earlier regimens How pharmacovigilance data can he...

#14 Advancing pharmacovigilance in Africa – Eleni Aklillu & Abbie Barry

March 24, 2022 08:00 - 37 minutes - 26.9 MB

Access to medical products has increased considerably in Africa in recent years, but safety monitoring systems haven’t exactly kept pace and many African countries still struggle to address safety issues. We sat down with Eleni Aklillu and Abbie Barry of the PROFORMA project to learn about their efforts to strengthen pharmacovigilance capacity in East Africa – especially within public health programmes. Tune in to find out: How comorbidities and genetic variation affect drug safety monitor...

#13 How to talk about risks – Alexandra Freeman

February 24, 2022 08:00 - 38 minutes - 27.4 MB

People’s perception of risk can vary greatly from person to person, making it challenging for healthcare professionals to communicate benefits and harms of medicines in a balanced fashion. Alexandra Freeman from the Winton Centre for Risk and Evidence Communication discusses how to give patients the information they need to decide what's best for them. Tune in to find out: Why people perceive risks so differently Why medical communicators should strive to inform rather than persuade How ...

Uppsala Reports Long Reads – Safety issues faced by refugee communities

January 27, 2022 10:00 - 25 minutes - 17.7 MB

The loss of vital health records is a universal problem for refugees. When their medical information goes missing, patients are less likely to receive the care they need and more likely to be prescribed the wrong treatments. Thankfully, the International Society of Pharmacovigilance Egypt Chapter and the Palestine Red Crescent Society are taking on this problem, to reduce medication errors and improve reporting practices. This episode is part of the Uppsala Reports Long Reads series – the m...

#12 Improving signal detection with vigiGroup – Jim Barrett & Joe Mitchell

December 16, 2021 15:00 - 23 minutes - 16.4 MB

Statistical tools can not only cut through the noise in large pharmacovigilance databases. They can also help identify more clinically meaningful patterns in the data. Uppsala Monitoring Centre’s Jim Barrett and Joe Mitchell explain how vigiGroup, a novel clustering algorithm, can bring value to signal detection. Tune in to find out: What the limits of traditional disproportionality analysis are How clustering algorithms can improve current signal detection practices How vigiGroup has he...

#11 Talking about vaccine safety – Anthony Cox & Daniel Salmon

November 03, 2021 12:00 - 28 minutes - 20.4 MB

With vaccine hesitancy on the rise and misinformation spreading like wildfire on social media, drug safety specialists may have a hard time knowing how to talk about side effects without affecting people’s trust in vaccinations. Anthony Cox from the University of Birmingham and Daniel Salmon from the Institute for Vaccine Safety share their best advice for balanced and responsible vaccine safety communication. Tune in to find out: Why we can’t allow bad actors to damage the drive for openn...

Uppsala Reports Long Reads – The KIDs List

October 05, 2021 14:00 - 31 minutes - 21.9 MB

It’s not always easy to choose the best medicine for a child. Some drugs are inappropriate for young patients, while others require special consideration or monitoring. For years, clinicians had only historical dogmas, word of mouth and their own experience to guide their choices. But a valuable new resource promises to change paediatric prescribing for the better. This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance magazine,...

Uppsala Reports Long Reads – Convincing the vaccine hesitant

August 30, 2021 11:00 - 34 minutes - 24.3 MB

Fuelled by disinformation and an array of other cultural and economic factors, vaccine hesitancy is one of the greatest global health communication challenges of our times. But to craft the empathetic and tailored communication strategies required to boost confidence in vaccines, we first need to understand the difference between anti-vaccination belief and vaccine hesitancy. This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilanc...

#10 – Tailoring drug therapy to your genes – Qun-Ying Yue

July 29, 2021 07:00 - 29 minutes - 20.5 MB

Genetic variation is one of the reasons people differ in their response to medicines. Understanding that variation can inform more refined choices of drugs and doses – ultimately preventing undesired side effects. Join us as we discuss past, present and future of pharmacogenomics with Uppsala Monitoring Centre’s Qun-Ying Yue. Tune in to find out: How genetic biomarkers can guide medicine use and dosing recommendations What we need to effectively implement genetic-based prescribing in clin...

#10 Tailoring drug therapy to your genes – Qun-Ying Yue

July 29, 2021 07:00 - 29 minutes - 20.5 MB

Genetic variation is one of the reasons people differ in their response to medicines. Understanding that variation can inform more refined choices of drugs and doses – ultimately preventing undesired side effects. Join us as we discuss past, present and future of pharmacogenomics with Uppsala Monitoring Centre’s Qun-Ying Yue. Tune in to find out: How genetic biomarkers can guide medicine use and dosing recommendations What we need to effectively implement genetic-based prescribing in clin...

#9 Keeping vaccines safe – Helena Sköld & Annette Rudolph

June 24, 2021 07:00 - 26 minutes - 18.4 MB

With COVID-19 vaccinations rolling at full speed in many countries, there’s a lot of talk about vaccine safety monitoring. But what exactly does that mean and how should we be interpreting data on side effects? Uppsala Monitoring Centre’s Helena Sköld and Annette Rudolph walk us through the basics of vaccine pharmacovigilance. Tune in to find out: How suspected side effects are reported and studied around the world Why a mere list of reported side effects says little about a vaccine’s saf...

Uppsala Reports Long Reads – Substandard and falsified COVID-19 vaccines in the Americas

May 27, 2021 06:00 - 21 minutes - 14.8 MB

While COVID-19 vaccinations are picking up speed in many wealthy countries, citizens of lower-income countries still face a long wait ­– and where demand exceeds supply, black markets tend to form. So to curb the spread of substandard and falsified products, says drug regulatory specialist Danini Marin, we must ensure that COVID-19 vaccines are distributed equitably around the world. This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmaco...

#8 How do we change behaviour around antimicrobial resistance?

April 27, 2021 06:00 - 47 minutes - 33.2 MB

Antimicrobial resistance (AMR) is not only a biological issue, but a complex social problem. As a consequence, changing the way patients, healthcare professionals and policymakers think about antibiotics will require input from both the natural and social sciences. In March 2021, the Uppsala Health Summit on “Managing antimicrobial resistance through behaviour change” tackled this very problem. We spoke to three key participants – Otto Cars, Eldar Shafir and Vanessa Carter – to learn more. ...

Uppsala Reports Long Reads – Into the infodemic

March 26, 2021 15:00 - 27 minutes - 19 MB

As the COVID-19 pandemic spread around the world, so did waves of viral misinformation. For pharmacovigilance manager Marco Tuccori, fighting the “infodemic” is a massive, but necessary, battle. This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance magazine, brought to you in audio format. Find the original article here. After the read, Marco tells us how the pandemic has affected his work at the University Hospital of Pisa, I...

#7 The challenge of rare diseases – Christina Ström Möller

February 26, 2021 08:00 - 24 minutes - 17.1 MB

By definition, a rare disease is one that only affects a handful of people in the world. But with more than 300 million people collectively affected by these conditions and only few approved treatments available, rare diseases constitute a major unmet medical need. Christina Ström Möller from Swedish biopharmaceutical company Sobi walks us through the scientific, commercial and human challenges of the rare disease landscape. Tune in to find out: What drug development, testing and distribut...

Uppsala Reports Long Reads – Africa integral to evolution of pharmacogenomics research

February 03, 2021 12:00 - 12 minutes - 8.65 MB

As the cradle of modern humanity, the African continent is home to populations with high levels of genetic diversity. But while this diversity has implications for the safety and efficacy of many drugs, African patients remain underrepresented in drug studies. In fact, while more than 400 medicines have pharmacogenetics information and public guidelines available, only 15 have been studied in African populations. Thankfully efforts to boost pharmacogenomics research in Africa are now underwa...

#6 Intuition in pharmacovigilance – Eugene van Puijenbroek

December 17, 2020 08:00 - 25 minutes - 17.6 MB

In the age of evidence-based medicine, we may be tempted to dismiss intuition – the quick and automatic thought process we call “sixth sense” or “gut feeling” – as unscientific guesswork. But in clinical decision-making, intuitive reasoning is just as important as the slower and more analytical causal reasoning that healthcare professionals are trained in. In fact, without it we would hardly be able to formulate new hypotheses. Together with Eugene van Puijenbroek from the Netherlands pharm...

Uppsala Reports Long Reads – Patient's advocate

November 26, 2020 08:00 - 9 minutes - 6.84 MB

In November 2020, longstanding UMC director Marie Lindquist began her well-earned retirement, leaving the reins of the organisation to her successor Hervé Le Louët. As she prepared to open a new chapter in her life, she sat down with Uppsala Reports to take a fond look back at an extraordinary career: a 40-year-long path that began with a knock on the door and turned her into one of the world’s leading advocates for patient safety. This episode is part of the Uppsala Reports Long Reads seri...

Uppsala Reports Long Reads – Vaccination errors risk harm and damage trust

October 23, 2020 09:00 - 9 minutes - 6.47 MB

Medication errors with vaccines can harm individual patients, but when they also undermine trust in public health programmes, serious problems can ripple across entire communities – as the Samoan healthcare crisis of 2018 dramatically showed. The Institute for Safe Medication Practices offers straightforward advice that could prevent those errors from happening again. This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance magazi...

#5 Restoring invisible and abandoned trials – Peter Doshi

September 30, 2020 15:00 - 34 minutes - 23.7 MB

Clinical trials are the “gold standard” of evidence-based medicine – the best way we have to test whether a drug is safe and effective before it enters the market. But if trial data is poorly reported or – even worse – left unpublished, how are we supposed to determine the true value of a medical treatment? Peter Doshi from the RIAT Support Center has made it his mission to fix the problem and improve data transparency for good. Tune in to find out: How publication and reporting biases aff...

#4 Communicating science through film – Matthew Barwick

August 27, 2020 12:00 - 28 minutes - 19.7 MB

Communication and public outreach are an important part of a scientist’s job. But researchers often find it daunting to translate their expert knowledge for a lay audience. In this episode, UMC’s video producer Matthew Barwick shares a report from the Global Science Film Festival 2019, including interviews with festival organiser Samer Angelone and other participants. Tag along to learn their best tips for effective science communication and how to harness the power of film to tell stories i...

#4 Communicating science through film – Matthew Barwick

August 27, 2020 12:00 - 28 minutes - 19.7 MB

Communication and public outreach are an important part of a scientist’s job. But researchers often find it daunting to translate their expert knowledge for a lay audience. In this episode, UMC’s video producer Matthew Barwick shares a report from the Global Science Film Festival 2019, including interviews with festival organiser Samer Angelone and other participants. Tag along to learn their best tips for effective science communication and how to harness the power of film to tell stories i...

Uppsala Reports Long Reads – Found in space

August 06, 2020 10:00 - 22 minutes - 15.5 MB

When reporting adverse reactions to drugs, people can choose from a plethora of different terms to describe their experience. But that makes it difficult and time-consuming for analysts to tell how similar two case safety reports are. A new method developed by UMC data scientist Lucie Gattepaille comes to the rescue. This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance magazine, brought to you in audio format. Find the origina...

Uppsala Reports Long Reads – 10 critical steps for patient safety

July 16, 2020 10:00 - 17 minutes - 12.1 MB

How do we minimise the harm caused to patients by medicines and medical devices? In October 2019, a diverse, multi-stakeholder group met in Erice, Italy and drew up a 10-point plan for improving patient safety worldwide. This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance magazine, brought to you in audio format. Find the original article here. After the read, we reach UMC director Marie Lindquist in her home in Gothenburg, ...

#3 Navigating the plant names jungle – Bob Allkin

June 25, 2020 08:00 - 40 minutes - 27.7 MB

Herbal substances can be found in a number of pharmaceutical drugs, cosmetics and food supplements – so it's not surprising that using plant names inconsistently can have serious health consequences. But with so much confusion around medicinal plant names, it’s easy to get it wrong. Bob Allkin from Royal Botanic Gardens, Kew explains what we can do about it. Tune in to find out: How common, scientific and pharmaceutical plant names differ How Kew’s Medicinal Plant Names Services works Ho...

#2 Why we should listen to patients – Linda Härmark

May 20, 2020 15:00 - 28 minutes - 19.7 MB

As the end users of medicines, patients can provide first-hand information on side effects. The issues they report add a richness to our understanding of medicine safety that we could never achieve by relying on healthcare professionals’ reports alone – so it’s crucial that we listen to them. Linda Härmark from the Netherlands pharmacovigilance centre Lareb tells us more. Tune in to find out: What patient reports reveal about people’s use of medicines How to make best use of the informati...

#2 Why we should listen to patients – Linda Härmark

May 20, 2020 15:00 - 28 minutes - 19.7 MB

As the end users of medicines, patients can provide first-hand information on side effects. The issues they report add a richness to our understanding of medicine safety that we could never achieve by relying on healthcare professionals’ reports alone – so it’s crucial that we listen to them. Linda Härmark from the Netherlands pharmacovigilance centre Lareb tells us more. Tune in to find out: What patient reports reveal about people’s use of medicines How to make best use of the informati...

Uppsala Reports Long Reads – Philosophy of science meets patient safety

May 13, 2020 07:00 - 12 minutes - 8.63 MB

Most of us want healthcare to be both patient-centric and evidence-based. But are those two goals compatible? Can we tailor healthcare to our unique circumstances­, while relying on the average statistical measurements that scientific evidence is based on? Emerging ideas in the philosophy of science are challenging a rigid reliance on evidence-based medicine and offering a more nuanced understanding of patient safety. This episode is part of the Uppsala Reports Long Reads series – the most ...

Uppsala Reports Long Reads – Ending the pregnant pause

April 24, 2020 08:00 - 25 minutes - 17.4 MB

Most women are prescribed some form of medication during their pregnancy. Yet we know very little about the safety of those medicines when they’re used during pregnancy or breastfeeding. New collaborative efforts are now underway to plug that knowledge gap. This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance magazine, brought to you in audio format. Find the text version here. Tune in to find out: Why clinical trials often ...

#1 Fighting the fakes – Aline Plançon

January 27, 2020 10:00 - 28 minutes - 19.7 MB

Fake medicines claim at least 200,000 lives every year, with the World Health Organization estimating that 1 in 10 medicines worldwide is now substandard or falsified. But with the market in illicit drugs worth up to $200 billion a year, and traffickers more likely to face a fine than jail time when they are caught, the financial incentives far outweigh the deterrents. So how do we put a stop to this deadly trade? Drug Safety Matters investigates with former Interpol officer and PMEDS progra...

#1 Fighting the Fakes – Aline Plançon

January 27, 2020 10:00 - 28 minutes - 19.7 MB

Fake medicines claim at least 200,000 lives every year, with the World Health Organization estimating that 1 in 10 medicines worldwide is now substandard or falsified. But with the market in illicit drugs worth up to $200 billion a year, and traffickers more likely to face a fine than jail time when they are caught, the financial incentives far outweigh the deterrents. So how do we put a stop to this deadly trade? Drug Safety Matters investigates with former Interpol officer and PMEDS progra...

Twitter Mentions

@umcglobalsafety 47 Episodes